Company identity
Browse spinoutsCompany number SC571106
Company profile
UK company SC571106, incorporated on 13 July 2017.
OrganLike Precision. Pioneering. 3D Organ Printing.
OrganLike is developing revolutionary organ printing technologies for future healthcare. Our novel organ printing technology will provide low-cost, hyper-real and rapid production of OrganLike models.
Company number SC571106
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
OrganLike develops technology that prints 3D surgical models from MRI and CT scans, allowing for trainee surgeons to conduct practice.
Organlike develops 3D printed hyper-real anatomical models for surgical training, surgical rehearsal and planning. Our mission is to support safer and more effective surgery. We aspire to be the global leader producing "hyper-real" organ models and tools for use in surgical simulation, medical training and for the medical device industry. Our hyper-real, high volume, generic surgical training models are produced using our unique materials and traditional manufacturing.
The company has launched the first home based vascular surgical training programme in the UK, in collaboration with Royal College of Surgeons of Edinburgh. The innovation has been recognised by a top award from British Vascular Society, and more recently by the Global Surgical Training Challenge Discovery Award. Supported by an Innovate UK grant, the Organlike technology has now been applied to train next-generation vascular surgeons in the UK and helping to train paediatric cardiac surgeons in developing countries.
1 Oct 2020 to 30 Jun 2021
Due to the current COVID-19 pandemic, the provision of surgical training has been severely disrupted with most training activities (in hospitals, medical schools, training centres and medical device companies) either postponed or cancelled. This will have a profound effect on long term healthcare provision. OrganLike is developing "hyper-realistic" synthe...